Mayfair Gold wins Ontario fast-track permitting status for Fenn-Gib as C$310m financing plans advance
Read More Pharma Industry News Regeneron Pharmaceuticals begins COVID-19 clinical trials of REGN-COV2 US biotech company Regeneron Pharmaceuticals has started the first clinical trial of its investigational dual antibody cocktail REGN-COV2… bypharmanewsdailyJune 12, 2020